shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > Entertainment News > Regional Indian Cinema News > Article > Malayalam Superstar Mammootty tests positive for Covid 19 shooting of his next halted

Malayalam Superstar Mammootty tests positive for Covid-19; shooting of his next halted

Updated on: 16 January,2022 03:56 PM IST  |  Mumbai
IANS |

Details about the star's health are awaited. 'CBI 5' is the fifth of a series of movies directed by K. Madhu and each of them has been a runaway hit

Malayalam Superstar Mammootty tests positive for Covid-19; shooting of his next halted

Picture Courtesy: Official Instagram Account, Mammootty

Malayalam superstar Mammootty tested Covid-19 positive on Sunday. In view of this development, the shooting of his movie franchise 'CBI 5' directed by K. Madhu has been suspended.


Details about the star's health are awaited. 'CBI 5' is the fifth of a series of movies directed by K. Madhu and each of them has been a runaway hit.


Mammootty played the lead role of Sethuraman Iyer in 'CBI 5'. The film has an impressive star cast comprising, among others, Mukesh and Jagathy Sreekumar.


This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK